A 7-year-old boy with acute onset of breathing difficulty.
Group A streptococcus (GAS) is a major bacterial pathogen affecting children globally. Approximately 15% of school-age children experience a symptomatic episode of GAS culture-positive pharyngitis each year. Although the incidence of invasive GAS disease under these circumstances is low (0.5%-2%), an increasing number of invasive GAS cases have been reported over the last 2 decades. This report describes a 7-year-old boy who, after being treated for GAS pharyngitis, developed a fatal streptococcal toxic shock syndrome.
Salas
Ariel A
AA
Department of Pediatrics, Hospital Agramont, La Paz, Bolivia. ariel.a.salas@gmail.com
D058186:Acute Kidney Injury / Q000209:etiology; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D002439:Cefotaxime / Q000627:therapeutic use; D002648:Child; D002981:Clindamycin / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D004630:Emergencies; D017809:Fatal Outcome; D005440:Fluid Therapy; D006470:Hemorrhage / Q000209:etiology; D006801:Humans; D007022:Hypotension / Q000209:etiology; D007442:Intubation, Intratracheal; D008297:Male; D010612:Pharyngitis / Q000150:complications* / Q000382:microbiology; D012121:Respiration, Artificial; D012128:Respiratory Distress Syndrome / Q000209:etiology* / Q000628:therapy; D012772:Shock, Septic / Q000209:etiology*; D013290:Streptococcal Infections / Q000150:complications* / Q000188:drug therapy / Q000382:microbiology; D013297:Streptococcus pyogenes / Q000302:isolation & purification*
D000900:Anti-Bacterial Agents; D002981:Clindamycin; D002439:Cefotaxime